Retain : Actualité Retain en direct - P7 | Bourse Reflex
Accueil > Tags > Retain

  • Toutes les actualités en rapport avec « Retain »

27/07 07:00 Retain - Strong growth in half-year revenue (+9.6%), growing order backlog (+12%) over one year

23/07 18:05 Retain - Description of the share buy-back programme approved by the AGM of 22 July 2015

21/07 23:00 Retain - Auplata announces first semester 2015 raw gold production: 143 kg - Favourable decision of Environmental Authority for Dieu Merci cyanide processing plant project

20/07 07:00 Retain - Prodways extends its market coverage to include Turkey and Israel and announces its first sale of 3D printing machines through a distributor

01/07 07:05 Retain - ECA Group, subsidiary of Groupe Gorgé, buys into humanoid robotics

10/06 07:00 Retain - Usine IO, the product prototyping and innovation platform, opens its capital to "French Tech Accélération" and Prodways Entrepreneurs

03/06 07:00 Retain - Groupe Gorgé strengthens its interests in the fire safety sector

01/06 07:00 Retain - Groupe Gorgé raises considerable funds for its 3D printing subsidiary - The Fimalac Group invests in Prodways Group

30/03 18:40 Retain - STORE ELECTRONIC SYSTEMS - 2014 annual results

25/10 09:15 Retain - The Mosaic Company and iGATE Patni Strengthen Partnership With Global Service Desk Deal

06/10 08:00 Retain - Partenariat stratégique entre HCL Technologies et CAST

29/08 10:20 Retain - W.P. Stewart and Co., Ltd. Reports Second Half and Full Year 2010 Financial Results and Provides Corporate Update

25/07 12:30 Retain - Raptor Pharmaceutical Meets Primary Endpoint in Its Phase 3 Clinical Trial of DR Cysteamine for Nephropathic Cystinosis

06/07 12:35 Retain - Raptor Pharmaceutical Receives Notices of Allowance for Two Key Patent Applications Protecting Its Cysteamine Portfolio

20/06 10:00 Retain - Pluristem and United Therapeutics Enter Into an Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension

06/06 12:35 Retain - Raptor Pharmaceutical Provides Update on Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis

18/05 08:00 Retain - Altamir Amboise invest in Vocalcom through the Apax Funds - The objective is to build a world leader in customer contact centre software

04/05 13:00 Retain - Talent Wars Rage Despite Recession, Finds Heidrick and Struggles

04/05 11:30 Retain - Acquisition of the "Les Maisons de Stéphanie" Group

26/04 10:30 Retain - NASDAQ OMX and ICE Issue Joint Statement on Superior Proposal